Aprea Therapeutics Inc

NASDAQ:APRE   2:32:38 PM EDT
4.71
+0.07 (+1.51%)
Earnings Announcements

Aprea Therapeutics Posts Q2 Loss Per Share Of $0.48

Published: 08/12/2021 21:13 GMT
Aprea Therapeutics Inc (APRE) - Aprea Therapeutics Reports Second Quarter 2021 Financial Results and Provides Update on Business Operations.
Q2 Loss per Share $0.48.
Q2 Earnings per Share Estimate $-0.47 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.45

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.41

More details on our Analysts Page.